Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.38 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5835817 | 0.98 | SIGMAR1 (0.40) | SIGMAR1POLBCA1CA2CHRNA7 | |
| SCHEMBL21314162 | 0.94 | SIGMAR1 (0.37) | SIGMAR1POLBCA1CA2CHRNA7 | |
| SCHEMBL21314160 | 0.90 | POLB (0.40) | SIGMAR1POLBCHRNA7CHRNA10CHRNA9 | |
| SCHEMBL925005 | 0.90 | CA1 (0.40) | POLBCA1CA2 | |
| Hydrochloric Acid SCHEMBL6115226 | 0.88 | CA1 (0.40) | POLBCA1CA2 | |
| SCHEMBL6115185 | 0.84 | CA1 (0.37) | POLBCA1CA2 | |
| SCHEMBL17316663 | 0.82 | MEN1 (0.54) | CA1CA2 | |
| SCHEMBL4546758 | 0.80 | EEF2K (0.35) | POLB | |
| Bromide SCHEMBL9661615 | 0.80 | CALM1 (0.44) | SIGMAR1CHRNA7CHRNA10CHRNA9 | |
| Phenyl Propionic Acid SCHEMBL3039200 | 0.79 | HDAC3 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4650498-A1 | FLUID CONTACTING DEVICE | Aurotec GmbH (AT) | 2025-11-19 | — | — | EP | claimed |
| US-11377535-B2 | Carbon fiber recovery compositions and methods | THE BOEING COMPANY (US) | 2022-07-05 | — | — | US | claimed |
| US-20200207940-A1 | Carbon Fiber Recovery Compositions and Methods | THE BOEING COMPANY | 2020-07-02 | — | — | US | claimed |
| US-10611892-B2 | Carbon fiber recovery compositions and methods | THE BOEING COMPANY (US) | 2020-04-07 | — | — | US | claimed |
| US-20180291174-A1 | Carbon Fiber Recovery Compositions and Methods | THE BOEING COMPANY | 2018-10-11 | — | — | US | claimed |
| US-7858802-B2 | Method of preparing ionic liquids | BASF SE (DE) | 2010-12-28 | — | — | US | claimed |
| US-12559586-B2 | Compositions containing uretdione groups crosslinking at low temperatures | COVESTRO DEUTSCHLAND AG (DE) | 2026-02-24 | — | — | US | disclosed |
| EP-4650498-A1 | FLUID CONTACTING DEVICE | Aurotec GmbH (AT) | 2025-11-19 | — | — | EP | disclosed |
| CN-115605525-B | Uretdione-containing compositions that crosslink at low temperatures | 科思创德国股份有限公司 | 2025-01-10 | — | — | CN | disclosed |
| EP-4157912-B1 | COMPOSITIONS CONTAINING URETDIONE GROUPS CROSSLINKING AT LOW TEMPERATURES | COVESTRO DEUTSCHLAND AG (DE) | 2024-05-22 | — | — | EP | disclosed |
| EP-3997183-B1 | METHOD FOR THE PRODUCTION OF ISOCYANURATES FROM URETDIONES | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2023-10-04 | — | — | EP | disclosed |
| US-11737345-B2 | Organic electronic material, ink composition containing same, and organic thin film, organic electronic element, organic electroluminescent element, lighting device, and display device formed therewith | RESONAC CORPORATION (JP) | 2023-08-22 | — | — | US | disclosed |
| US-20230192941-A1 | COMPOSITIONS CONTAINING URETDIONE GROUPS CROSSLINKING AT LOW TEMPERATURES | COVESTRO DEUTSCHLAND AG (DE) | 2023-06-22 | — | — | US | disclosed |
| EP-1648845-A1 | METHOD FOR EXTRACTING IMPURITIES USING IONIC LIQUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2006-04-26 | — | — | EP | disclosed |
| US-7005282-B2 | Enzymes coated with ionic liquid | POSCO AND POSTECH FOUNDATION (KR) | 2006-02-28 | — | — | US | disclosed |
| WO-2005111151-A1 | SECONDARY TREATMENT OF PIGMENTS IN IONIC LIQUIDS | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2005-11-24 | — | — | WO | disclosed |
| WO-2005070896-A1 | MEHTOD FOR PRODUCING IONIC LIQUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2005-08-04 | — | — | WO | disclosed |
| WO-2005019183-A1 | METHOD FOR THE PRODUCTION OF PURIFIED 1,3-SUBSTITUTED IMIDAZOLIUM SALTS | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-03 | — | — | WO | disclosed |
| WO-2005019137-A1 | METHOD FOR EXTRACTING IMPURITIES USING IONIC LIQUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-03 | — | — | WO | disclosed |
| US-20040087462-A1 | Enzymes cooated with ionic liquid | POSCO (KR) | 2004-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559586-B2 | Compositions containing uretdione groups crosslinking at low temperatures | URB2, UQCRB, UQCRC2 | SIGMAR1 400/4885POLB 2146/4885CA1 1660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.